FRANCO, Massimo
 Distribuzione geografica
Continente #
NA - Nord America 11.205
AS - Asia 4.484
EU - Europa 4.216
SA - Sud America 1.262
Continente sconosciuto - Info sul continente non disponibili 322
AF - Africa 165
OC - Oceania 16
Totale 21.670
Nazione #
US - Stati Uniti d'America 10.874
SG - Singapore 1.756
IT - Italia 1.477
CN - Cina 1.101
BR - Brasile 984
SE - Svezia 522
HK - Hong Kong 521
DE - Germania 430
RU - Federazione Russa 389
FI - Finlandia 354
UA - Ucraina 304
VN - Vietnam 264
FR - Francia 251
GB - Regno Unito 217
IN - India 142
ID - Indonesia 135
BD - Bangladesh 128
CA - Canada 121
AR - Argentina 78
IQ - Iraq 70
CO - Colombia 55
MX - Messico 55
JP - Giappone 54
TR - Turchia 51
EC - Ecuador 44
PK - Pakistan 43
ZA - Sudafrica 42
NL - Olanda 40
VE - Venezuela 37
CI - Costa d'Avorio 36
ES - Italia 36
IE - Irlanda 34
PY - Paraguay 30
BE - Belgio 28
SA - Arabia Saudita 27
CR - Costa Rica 26
PL - Polonia 26
HN - Honduras 24
MY - Malesia 23
AT - Austria 21
LT - Lituania 21
MA - Marocco 21
SV - El Salvador 20
PH - Filippine 17
UZ - Uzbekistan 17
CZ - Repubblica Ceca 16
IR - Iran 16
TH - Thailandia 16
JM - Giamaica 15
NI - Nicaragua 15
AU - Australia 14
CW - ???statistics.table.value.countryCode.CW??? 14
CL - Cile 13
EG - Egitto 13
TT - Trinidad e Tobago 13
CH - Svizzera 12
UY - Uruguay 12
KR - Corea 11
DZ - Algeria 10
GP - Guadalupe 10
KZ - Kazakistan 10
GT - Guatemala 9
NP - Nepal 9
PR - Porto Rico 9
AE - Emirati Arabi Uniti 8
DO - Repubblica Dominicana 8
JO - Giordania 8
KE - Kenya 8
NG - Nigeria 8
PE - Perù 7
AZ - Azerbaigian 6
ET - Etiopia 6
IL - Israele 6
RO - Romania 6
TN - Tunisia 6
BY - Bielorussia 5
KG - Kirghizistan 5
PS - Palestinian Territory 5
AM - Armenia 4
BH - Bahrain 4
EE - Estonia 4
YE - Yemen 4
EU - Europa 3
LB - Libano 3
MD - Moldavia 3
OM - Oman 3
PT - Portogallo 3
SN - Senegal 3
SY - Repubblica araba siriana 3
AL - Albania 2
BG - Bulgaria 2
BO - Bolivia 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
KW - Kuwait 2
MG - Madagascar 2
MK - Macedonia 2
MR - Mauritania 2
MU - Mauritius 2
Totale 21.334
Città #
Ashburn 1.176
Singapore 932
Fairfield 910
Chandler 726
San Jose 725
Jacksonville 679
Woodbridge 587
Houston 527
Hong Kong 518
Milan 465
Nyköping 372
Seattle 367
Cambridge 360
Ann Arbor 320
Wilmington 304
Beijing 299
Council Bluffs 242
New York 228
Helsinki 186
Lawrence 169
Roxbury 166
Nanjing 165
Bari 164
Los Angeles 153
Dallas 149
Lauterbourg 148
Boardman 143
Rome 134
Princeton 109
Santa Clara 108
São Paulo 98
Des Moines 87
Ho Chi Minh City 87
Washington 84
Brooklyn 76
Munich 71
Hanoi 59
Chicago 55
Shenyang 51
San Diego 47
Buffalo 46
Jiaxing 46
Columbus 45
Inglewood 45
London 42
Nanchang 42
Jakarta 39
Grottaglie 38
Abidjan 36
Figino 33
Frankfurt am Main 33
Hebei 33
Dublin 32
Tianjin 32
Turin 32
Baghdad 31
Montreal 31
Tokyo 31
Napoli 30
San Francisco 27
Brussels 26
North Bergen 26
Moscow 25
Rio de Janeiro 25
Toronto 25
Turku 25
Guangzhou 23
Johannesburg 23
Atlanta 22
Denver 22
Falkenstein 22
Phoenix 22
San José 21
Warsaw 21
Amsterdam 20
Asunción 20
Belo Horizonte 20
Guayaquil 20
Bitonto 19
Mexico City 19
Naples 19
Shanghai 19
Paris 18
Porto Alegre 18
Changsha 17
Dearborn 17
Orem 17
San Salvador 16
Boston 15
Chennai 15
Dhaka 15
Florence 15
Jinan 15
Tashkent 15
Brasília 14
Goiânia 14
Jeddah 14
Managua 14
New Delhi 14
Nuremberg 14
Totale 13.731
Nome #
S-preactivated thiolated glycol chitosan useful to combine mucoadhesion and drug delivery 327
Physicochemical Stability of the Extemporaneous Ibuprofen Oral Suspension in "Wagner" Base 309
Spray-dried mucoadhesives for intravesical drug delivery using N-acetylcysteine- and glutathione-glycol chitosan conjugates 265
Characterization of minoxidil/hydroxypropyl-β-cyclodextrin inclusion complex in aqueous alginate gel useful for alopecia management: Efficacy evaluation in male rat 262
Preactivated thiolated glycogen as mucoadhesive polymer for drug delivery 255
Characterization of minoxidil/hydroxypropyl-β-cyclodextrin inclusion complex in aqueous alginate gel useful for alopecia management: Efficacy evaluation in male rat 227
2-Phenylimidazo[1,2-a]pyridine-containing ligands of the 18-kDa translocator protein (TSPO) behave as agonists and antagonists of steroidogenesis in a mouse leydig tumor cell line. 225
Dasatinib/HP-β-CD inclusion complex based aqueous formulation as a promising tool for the treatment of paediatric neuromuscular disorders 223
Taste masking of propranolol hydrochloride by microbeads of EUDRAGIT® E PO obtained with prilling technique for paediatric oral administration 212
Drug delivery nanovectors based on SPIONS for targeted therapy of hepatocellular carcinoma 210
A new complex of curcumin with sulfobutylether-β-cyclodextrin: characterization studies and in vitro evaluation of cytotoxic and antioxidant activity on HepG-2 cells 207
Sorafenib delivery nanoplatform based on superparamagnetic iron oxide nanoparticles magnetically targets hepatocellular carcinoma 206
Oxazepam-Dopamine Conjugates Increase Dopamine Delivery into Striatum of Intact Rats 204
A comparative study of chitosan and chitosan/cyclodextrin nanoparticles as potential carriers for the oral delivery of small peptides 203
Principi di calcolo farmaceutico 202
Bridging Pharmaceutical Chemistry with Drug and Nanoparticle Targeting to Investigate the Role of the 18-kDa Translocator Protein TSPO. 201
A Novel PET Imaging Probe for the Detection and Monitoring of Translocator Protein 18 kDa Expression in Pathological Disorders 198
Antitumor Potential of Conjugable Valinomycins Bearing Hydroxyl Sites: In Vitro Studies 195
Delivery of proapoptotic agents in glioma cell lines by TSPO ligand–dextran nanogels 195
Alginate-Based Hydrogel Containing Minoxidil/Hydroxypropyl-β-Cyclodextrin Inclusion Complex for Topical Alopecia Treatment 194
Spray Dried Chitosan Microparticles for Intravesical Delivery of Celecoxib: Preparation and Characterization. 181
TSPO ligand-methotrexate prodrug conjugates: Design, synthesis, and biological evaluation 181
Changes in GABAA receptor gene expression induced by withdrawal of, but not by long-term exposure to, zaleplon or zolpidem 178
b-Cyclodextrin in personal care formulation: role on the complexation of malodors causing molecules 168
Effect of cyclodextrins on physico-chemical and release properties of Eudragit RS 100 microparticles containing glutathione 167
Pharmaceutical preformulation studies and paediatric oral formulations of sodium dichloroacetate 163
The hydroxypropyl‐β‐cyclodextrin‐minoxidil inclusion complex improves the cardiovascular and proliferative adverse effects of minoxidil in male rats: Implications in the treatment of alopecia 162
Colonic budesonide delivery by multistimuli alginate/Eudragit® FS 30D/inulin-based microspheres as a paediatric formulation 159
Enzymatic Resolution of α-Methyleneparaconic Acids and Evaluation of their Biological Activity 159
Spray-dried mucoadhesive microparticles based on S-protected thiolated hydroxypropyl-β-cyclodextrin for budesonide nasal delivery 159
New biodegradable hydrogels based on inulin and α,β-polyaspartylhydrazide designed for colonic drug delivery: in vitro release of glutathione and oxytocin 158
Alpidem analogues containinig a GABA or glycine moiety as new anticonvulsant agents 156
A rapid screening tool for estimating the potential of 2-hydroxypropyl-beta-cyclodextrin complexation for solubilization purposes 155
Characterization and release studies of liposomal gels containing glutathione/cyclodextrins complexes potentially useful for cutaneous administration 154
Transferrin Functionalized Liposomes Loading Dopamine HCl: Development and Permeability Studies across an In Vitro Model of Human Blood-Brain Barrier 150
Translocator Protein Ligand-PLGA conjugates nanoparticles for 5-Fluorouracil Delivery to Glioma Cancer Cells 150
Single-dose extended-toxicity preclinical study on novel radiotracer formulations for use in the diagnosis of neuroendocrine tumor and neurodegenerative disorders 149
Propofol analogues. Synthesis, relationships between structure and affinity at GABAA receptor in rat brain, and differential electrophysiological profile at recombinant human GABAA receptors 146
B-CYCLODEXTRIN IN PERSONAL CARE FORMULATION: ROLE ON THE COMPLEXATION OF MALODORS CAUSING MOLECULES 145
From oil to microparticulate by prilling technique: Production of polynucleate alginate beads loading Serenoa Repens oil as intestinal delivery systems 144
Chitosan/sulfobutylether-β-cyclodextrin based nanoparticles coated with thiolated hyaluronic acid for indomethacin ophthalmic delivery 142
CAT microscopy: a novel tool for 3D cell investigation 141
Pharmaceutical development of novel lactate-based 6-fluoro-L-DOPA formulations 139
CAT microscopy: a novel tool for 3D cell investigation 137
β-cyclodextrin in personal care formulations: role on the complexation of malodours causing molecules 137
PEGylated solid lipid nanoparticles for brain delivery of lipophilic kiteplatin Pt(IV) prodrugs: An in vitro study 137
In vitro targeting and imaging the translocator protein TSPO 18-kDa through G(4)-PAMAM-FITC labeled dendrimer 136
2-Phenylimidazo[1,2-a]pyridine derivatives as ligands for peripheral benzodiazepine receptors: stimulation of neurosteroid synthesis and anticonflict action in rats 135
Magnetic implants in vivo guiding sorafenib liver delivery by superparamagnetic solid lipid nanoparticles 135
Natural dendrimers: Synthesis and in vitro characterization of glycogen-cysteamine conjugates 133
Water-soluble salts of aminoacid esters of the anaesthetic agent Propofol 132
Synthesis and anticonvulsant activity of some 1,2,3,3a-tetrahydropyrrolo[2,1-b]-benzothiazol-, -thiazol- or -oxazol-1-ones in rodents. 131
Synthesis of the [3H] labelled potent and selective peripheral benzodiazepine receptor ligand CB34 129
Nanoparticelle a base di Eudragit® RS 100 contenenti ciclodestrine utili per la somministrazione transmucosale di Glutatione 129
Synthesis, characterization, and in vitro evaluation of a new TSPO-selective bifunctional chelate ligand 127
Thiolated hydroxypropyl-β-cyclodextrin as mucoadhesive excipient for oral delivery of budesonide in liquid paediatric formulation 127
Determination of hydrophile-lipophile balance of some polyethoxylated non-ionic surfactants by reversed-phase thin layer chromatography 127
Synthesis, characterization, and in vitro evaluation of new coordination complexes of platinum(II) and rhenium(I) with a ligand targeting the translocator protein (TSPO) 126
Griseofulvin/carrier blends: application of partial least squares (PLS) regression analysis for estimating the factors affecting the dissolution efficiency. 126
Direct cyclodextrin-based powder extrusion 3D printing for one-step production of the BCS class II model drug niclosamide 126
In vitro evaluation of N-acyllactam esters of indomethacin as dermal prodrugs 125
Triphenylphosphane Pt(II) complexes containing biologically active natural polyphenols: Synthesis, crystal structure, molecular modeling and cytotoxic studies 125
Design and synthesis of grafted TSPO ligand-amino functionalized silica-coated quantum dots 123
New ethanol and propylene glycol free gel formulations containing a minoxidil-methyl-β-cyclodextrin complex as promising tools for alopecia treatment 123
Synthesis and benzodiazepine receptor binding of some 4H-pyrimido[2,1-b]benzothiazol-4-ones 122
Complexation of phenytoin with some hydrophilic cyclodextrins: effect on aqueous solubility, dissolution rate, and anticonvulsant activity in mice 120
Combined Eudragit RS100 cyclodextrin nanoparticles intended for transmucosal administration of Glutathione 120
Evaluation of new propofol aqueous solutions for intravenous anesthesia 120
Celecoxib-hydroxypropyl-β-cyclodextrin inclusion complex in a chitosan/PEO-PPO-PEO block copolymer matrix: Structural effect and drug release 118
Comparative study of gels containing a minoxidil/MebCD complex with conventional formulation 118
2-PHENYL-IMIDAZO[1,2-A]PYRIDINE DERIVATIVES HAVING HIGH IN VITRO AFFINITY AND SELECTIVITY FOR PERIPHERAL BENZODIAZEPINE RECEPTORS: STIMULATE OF STEROIDOGENESIS IN ADRENAL AND BRAIN 117
Preparation and evaluation of eudragit RS 100 microparticles containing glutathione and 2-hydroxypropyl-b-cyclodextrin 117
Stability data of extemporaneous suspensions of hydroxychloroquine sulphate in oral liquid bases after tablet manipulation 117
Eudragit RS 100 microparticles containing 2-hydroxypropyl-beta-cyclodextrin and glutathione: physicochemical characterization, drug release and transport studies 116
Synthesis and benzodiazepine receptor binding of some imidazo-, pyrimido [2,1-b] benzoxazoles and pyrimido [1,2-a] benzimidazoles 116
COLD KITS BASED ON PSMA LIGANDS FOR THE PREPARATION OF RADIOPHARMACEUTICALS 114
Determinazione del bilancio idrofilo-lipofilo di alcuni tensioattivi non-ionici mediante cromatografia planare in fase inversa 114
Effect of some hydrophilic cyclodextrins on the solubility, dissolution rate and in vitro percutaneous penetration of oxazepam 114
Investigating the prilling/vibration technique to produce gastric-directed drug delivery systems for misoprostol 113
IMIDAZOPYRIDINE DERIVATIVES AS POTENTIAL PRODRUGS FOR TARGETING OF GABA AND GLYCINE TO THE BRAIN 113
Evaluation of new propofol aqueous solutions for intravenous anesthesia 113
Synthesis and benzodiazepine receptor binding of some imidazo- and pyrimido [2,1-b] benzothiazoles 113
DEVELOPMENT OF MUCOADHESIVE MICROSPHERES AS CELECOXIB DELIVERY SYSTEMS IN THE BLADDER 112
Frog intestinal sac as an in vitro method for the assessment of intestinal permeability in humans: Application to carrier transported drugs 112
Structural modifications and antimicrobial activity of N-cycloalkenyl-2-acylalkylidene-2,3-dihydro-1,3-benzothiazoles 111
New nanostructured self-assemblong inulin-a-tocopherol bioconjugates for biomedical applications 110
Microfluidic preparation and in vitro evaluation of iRGD-functionalized solid lipid nanoparticles for targeted delivery of paclitaxel to tumor cells 110
COMPARATIVE STUDY OF GELS CONTAINING A MINOXIDIL/MEbCD COMPLEX WITH CONVENTIONAL FORMULATIONS 109
Griseofulvin/carrier blends: identification of factors affecting the dissolution efficiency of solid dispersions using carrier molecular descriptors and Partial Least-Squares (PLS) regression analysis 108
In vitro targeting and imaging the translocator protein TSPO 18-kDa through G(4)-PAMAM–FITC labeled dendrimer 106
Combined Chitosan-Cyclodextrin Nanoparticles: A Potential Carrier For The Transmucosal Administration Of Glutathione 106
Relationship between dissolution efficiency of Oxazepam/carrier blends and drug and carrier molecular descriptors using multivariate regression analysis 106
Prediction of solubility enhancement for drugs in concentrated aqueous solutions multivariate regression analysis 105
N- Alchenyl Acylketene S,N-Acetals from 2,3-Dihydro-1,3-benzothiazoles and Carboxylic Anydrides. X-Ray Molecular Structure of 2- (Butyrylmethylene)-N(cyclohex-1-enyl)-2,3-dihydro-1,3-benzothiazole 105
Synthesis, in vitro and in vivo cytotoxicity, and prediction of the intestinal absorption of substituted 2-ethoxycarbonyl-imidazo[2,1-b]benzothiazoles 105
Synthesis and binding affinity of 2-phenylimidazo[1,2-a]pyridine derivatives for both central and peripheral benzodiazepine receptors. A new series of high-affinity and selective ligands for the peripheral type 105
Stability of Diazepam Enema Extemporaneous Formulation in Manzoni Base 105
Valproic acid hydrophilic cyclodextrin complexes and valproic acid-solid 103
New biodegradable hydrogels based on inulin and "alpha","beta"-polyaspartylhydrazide designed for colonic drug delivery: in vitro release of peptides glutathione and oxytocin 103
Relationship between hydrophilic-lipophilic balance and behaviour in reversed-phase thin-layer chromatography of some non-ionic surfactants 101
Totale 14.869
Categoria #
all - tutte 88.158
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.158


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022933 0 0 0 0 39 80 67 55 96 111 178 307
2022/20231.982 325 195 114 186 274 256 24 209 306 24 48 21
2023/2024866 64 141 60 45 94 234 38 59 11 13 20 87
2024/20253.336 116 55 291 110 102 252 340 294 138 176 495 967
2025/20266.403 868 298 397 718 602 331 750 248 621 586 202 782
2026/20271.932 192 312 532 884 12 0 0 0 0 0 0 0
Totale 21.670